(QDEL) Quidel - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74838J1016

QDEL: Tests, Instruments, Reagents, Kits, Assays, Diagnostics

QuidelOrtho Corporation (NASDAQ: QDEL) is a leader in diagnostic testing solutions, operating across four distinct business units: Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics. The Labs division specializes in clinical chemistry and immunoassay instruments, providing critical data for patient health evaluation and disease management. Their Transfusion Medicine unit ensures compatibility and safety in blood transfusions and donor screening. The Point-of-Care segment offers rapid testing solutions for diverse healthcare settings, while Molecular Diagnostics focuses on innovative PCR and syndromic testing.

With a market cap of approximately $2.9 billion, QuidelOrtho is strategically positioned in the diagnostics industry, offering a broad range of testing solutions. Their products are distributed directly and through a global network, reaching physician offices, hospitals, and clinical laboratories. This extensive distribution underscores their commitment to accessibility and reliability in healthcare diagnostics.

QuidelOrthos financials, including a forward P/E of 17.27 and P/S of 1.04, highlight their potential for growth and profitability. Their global presence in North America, Europe, and other regions further solidifies their market reach. Established in 1979 and headquartered in San Diego, QuidelOrtho continues to innovate, making it a notable player in the diagnostics sector.

Additional Sources for QDEL Stock

QDEL Stock Overview

Market Cap in USD 2,695m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Supplies
IPO / Inception 1991-02-01

QDEL Stock Ratings

Growth 5y -56.4%
Fundamental -45.8%
Dividend 0.0%
Rel. Strength Industry -24.6
Analysts 3.63/5
Fair Price Momentum 30.01 USD
Fair Price DCF 28.44 USD

QDEL Dividends

No Dividends Paid

QDEL Growth Ratios

Growth Correlation 3m -70.1%
Growth Correlation 12m -6.3%
Growth Correlation 5y -93.3%
CAGR 5y -13.39%
CAGR/Max DD 5y -0.15
Sharpe Ratio 12m -1.83
Alpha -30.59
Beta 0.38
Volatility 48.36%
Current Volume 856k
Average Volume 20d 739.1k
What is the price of QDEL stocks?
As of March 16, 2025, the stock is trading at USD 36.12 with a total of 855,971 shares traded.
Over the past week, the price has changed by -11.47%, over one month by -10.97%, over three months by -17.61% and over the past year by -23.93%.
Is Quidel a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Quidel (NASDAQ:QDEL) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -45.84 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QDEL as of March 2025 is 30.01. This means that QDEL is currently overvalued and has a potential downside of -16.92%.
Is QDEL a buy, sell or hold?
Quidel has received a consensus analysts rating of 3.63. Therefor, it is recommend to hold QDEL.
  • Strong Buy: 2
  • Buy: 2
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
What are the forecast for QDEL stock price target?
According to ValueRays Forecast Model, QDEL Quidel will be worth about 32.4 in March 2026. The stock is currently trading at 36.12. This means that the stock has a potential downside of -10.27%.
Issuer Forecast Upside
Wallstreet Target Price 51.1 41.6%
Analysts Target Price 51.1 41.6%
ValueRay Target Price 32.4 -10.3%